Hiromori Y1, Ido A, Aoki A, Kimura T, Nagase H, Nakanishi T.
Biol Pharm Bull. 2016;39(10):1596-1603.We investigated the ability of group 15 compounds with a triphenyl substituent to bind to and activate human retinoic X receptor (RXR) and peroxisome proliferator-activated receptor (PPAR) γ and their ability to activate the receptor. Triphenylphosphine oxide (TPPO) transcriptionally activated both RXR and PPARγ. Triphenylbismuth (TPBi) transcriptionally activated PPARγ but not RXR. However, TPBi s ... Read More